Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGPAT2 | O15120 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.38 |
| ▸ | PRNP | P04156 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10284741 | 0.88 | AGPAT2 (0.46) | AGPAT2SMN1; SMN2POLBALDH1A1KDM4E | |
| SCHEMBL10249098 | 0.85 | POLB (0.41) | SMN1; SMN2MAPTHSD17B10NPC1RAB9A | |
| SCHEMBL10248957 | 0.82 | SMN1; SMN2 (0.43) | AGPAT2SMN1; SMN2MAPTHSD17B10NPC1 | |
| SCHEMBL10249152 | 0.82 | SMN1; SMN2 (0.44) | AGPAT2SMN1; SMN2MAPTHSD17B10NPC1 | |
| SCHEMBL10249110 | 0.80 | SMN1; SMN2 (0.40) | AGPAT2SMN1; SMN2MAPTHSD17B10NPC1 | |
| SCHEMBL10249343 | 0.79 | TSHR (0.42) | AGPAT2SMN1; SMN2MAPTHSD17B10NPC1 | |
| SCHEMBL10249306 | 0.79 | SMN1; SMN2 (0.40) | AGPAT2SMN1; SMN2MAPTHSD17B10NPC1 | |
| SCHEMBL10249150 | 0.79 | TLR8 (0.41) | AGPAT2SMN1; SMN2MAPTHSD17B10NPC1 | |
| SCHEMBL10252630 | 0.79 | POLB (0.40) | AGPAT2SMN1; SMN2MAPTHSD17B10NPC1 | |
| SCHEMBL10249017 | 0.79 | MAPT (0.40) | AGPAT2SMN1; SMN2MAPTHSD17B10NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461181-B2 | Fused heterocyclic compound and use thereof | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2013-06-11 | — | — | US | disclosed |
| US-8273764-B2 | Fused heterocyclic compounds and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-09-25 | — | — | US | disclosed |
| US-20120178779-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED | 2012-07-12 | — | — | US | disclosed |
| WO-2012057265-A1 | PEST CONTROL COMPOSITION AND METHOD FOR CONTROLLING PESTS | 住友化学株式会社 (JP) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012057266-A1 | PEST CONTROL COMPOSITION AND METHOD FOR CONTROLLING PESTS | 住友化学株式会社 (JP) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012057268-A1 | PEST CONTROL COMPOSITION AND METHOD FOR CONTROLLING PESTS | 住友化学株式会社 (JP) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012057269-A1 | HARMFUL ANIMAL CONTROL COMPOSITION AND METHOD FOR CONTROLLING HARMFUL ANIMALS | 住友化学株式会社 (JP) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012057264-A1 | PEST CONTROL COMPOSITION AND METHOD FOR CONTROLLING PESTS | 住友化学株式会社 (JP) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012057260-A1 | PEST CONTROL COMPOSITION AND METHOD FOR CONTROLLING PESTS | 住友化学株式会社 (JP) | 2012-05-03 | — | — | WO | disclosed |
| WO-2012057273-A1 | HARMFUL ANIMAL CONTROL COMPOSITION AND METHOD FOR CONTROLLING HARMFUL ANIMALS | 住友化学株式会社 (JP) | 2012-05-03 | — | — | WO | disclosed |
| US-20120015975-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178779-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF | C3AR1, C9, C5 | AGPAT2 3286/4885SMN1; SMN2 1524/4885MAPT 4423/4885 |
| US-20120015975-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF | C3AR1, C9, C5 | AGPAT2 3286/4885SMN1; SMN2 1524/4885MAPT 4423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.